{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T10:13:21Z","timestamp":1789726401705,"version":"4.0.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2020,4,9]],"date-time":"2020-04-09T00:00:00Z","timestamp":1586390400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,9]],"date-time":"2020-04-09T00:00:00Z","timestamp":1586390400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000133","name":"Agency for Healthcare Research and Quality","doi-asserted-by":"publisher","award":["R01HS025984"],"award-info":[{"award-number":["R01HS025984"]}],"id":[{"id":"10.13039\/100000133","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Saf"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1007\/s40264-020-00930-7","type":"journal-article","created":{"date-parts":[[2020,4,9]],"date-time":"2020-04-09T03:02:35Z","timestamp":1586401355000},"page":"661-668","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Evidence of Clinically Meaningful Drug\u2013Drug Interaction With Concomitant Use of Colchicine and Clarithromycin"],"prefix":"10.1007","volume":"43","author":[{"given":"Lorenzo","family":"Villa Zapata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip D.","family":"Hansten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Horn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard D.","family":"Boyce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila","family":"Gephart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vignesh","family":"Subbian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5006-9394","authenticated-orcid":false,"given":"Daniel C.","family":"Malone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,9]]},"reference":[{"key":"930_CR1","doi-asserted-by":"crossref","unstructured":"Nuki G, Simkin PA. A concise history of gout and hyperuricemia and their treatment. Arthritis Res Ther [Internet]. BioMed Central; 2006;8:S1.","DOI":"10.1186\/ar1906"},{"issue":"4","key":"930_CR2","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1136\/annrheumdis-2015-208690","volume":"75","author":"S Ozen","year":"2016","unstructured":"Ozen S, Demirkaya E, Erer B, et al. EULAR recommendations for the management of familial Mediterranean fever. Ann Rheum Dis. 2016;75(4):644\u201351. https:\/\/doi.org\/10.1136\/annrheumdis-2015-208690.","journal-title":"Ann Rheum Dis."},{"key":"930_CR3","unstructured":"Leung YY, Yao Hui LL, Kraus VB. Colchicine--Update on mechanisms of action and therapeutic uses. Semin Arthritis Rheum [Internet]. NIH Public Access; 2015;45:341\u201350."},{"key":"930_CR4","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/med.20097","volume":"28","author":"B Bhattacharyya","year":"2008","unstructured":"Bhattacharyya B, Panda D, Gupta S, Banerjee M. Anti-mitotic activity of colchicine and the structural basis for its interaction with tubulin. Med Res Rev. 2008;28:155\u201383.","journal-title":"Med Res Rev"},{"key":"930_CR5","doi-asserted-by":"publisher","first-page":"13560","DOI":"10.1021\/bi00212a023","volume":"32","author":"DL Sackett","year":"1993","unstructured":"Sackett DL, Varma JK. Molecular mechanism of colchicine action: induced local unfolding of \u03b2-tubulin. Biochemistry. 1993;32:13560\u20135.","journal-title":"Biochemistry"},{"key":"930_CR6","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.tcb.2006.08.002","volume":"16","author":"JP Caviston","year":"2006","unstructured":"Caviston JP, Holzbaur ELF. Microtubule motors at the intersection of trafficking and transport. Trends Cell Biol. 2006;16:530\u20137.","journal-title":"Trends Cell Biol"},{"key":"930_CR7","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1007\/s00296-004-0442-4","volume":"25","author":"E Ben-Chetrit","year":"2005","unstructured":"Ben-Chetrit E, Fischel R, Hinz B, Levy M. The effects of colchicine and hydroxychloroquine on the cyclo-oxygenases COX-1 and COX-2. Rheumatol Int. 2005;25:332\u20135.","journal-title":"Rheumatol Int"},{"key":"930_CR8","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1007\/s11926-008-0036-3","volume":"10","author":"G Nuki","year":"2008","unstructured":"Nuki G. Colchicine: Its mechanism of action and efficacy in crystal-induced inflammation. Curr Rheumatol Rep. 2008;10:218\u201327.","journal-title":"Curr Rheumatol Rep"},{"key":"930_CR9","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1172\/JCI118147","volume":"96","author":"BN Cronstein","year":"1995","unstructured":"Cronstein BN, Molad Y, Reibman J, Balakhane E, Levin RI, Weissmann G. Colchicine alters the quantitative and qualitative display of selectins on endothelial cells and neutrophils. J Clin Invest. 1995;96:994\u20131002.","journal-title":"J Clin Invest"},{"key":"930_CR10","doi-asserted-by":"publisher","first-page":"407","DOI":"10.3109\/15563650.2010.495348","volume":"48","author":"Y Finkelstein","year":"2010","unstructured":"Finkelstein Y, Aks SE, Hutson JR, Juurlink DN, Nguyen P, Dubnov-Raz G, et al. Colchicine poisoning: the dark side of an ancient drug. Clin Toxicol. 2010;48:407\u201314.","journal-title":"Clin Toxicol"},{"key":"930_CR11","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1002\/phar.1125","volume":"32","author":"BA Todd","year":"2012","unstructured":"Todd BA, Billups SJ, Delate T, Canty KE, Kauffman AB, Rawlings JEWT. Assessment of the association between colchicine therapy and serious adverse events. Pharmacotherapy. 2012;32:974\u201380.","journal-title":"Pharmacotherapy"},{"key":"930_CR12","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.medcli.2012.01.027","volume":"139","author":"E Villama\u00f1\u00e1n","year":"2012","unstructured":"Villama\u00f1\u00e1n E, Larrubia Y, Ruano M. Colchicine: what\u2019s up, doc? Med Clin (Barc). 2012;139:295\u20139.","journal-title":"Med Clin (Barc)"},{"key":"930_CR13","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.1002\/art.30389","volume":"63","author":"RA Terkeltaub","year":"2011","unstructured":"Terkeltaub RA, Furst DE, Digiacinto JL, Kook KA, Davis MW. Novel evidence-based colchicine dose-reduction algorithm to predict and prevent colchicine toxicity in the presence of cytochrome P450 3A4\/P-glycoprotein inhibitors. Arthritis Rheum. 2011;63:2226\u201337.","journal-title":"Arthritis Rheum"},{"key":"930_CR14","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.mcna.2011.03.012","volume":"95","author":"JM Zuckerman","year":"2011","unstructured":"Zuckerman JM, Qamar F, Bono BR. Review of macrolides (azithromycin, clarithromycin), ketolids (telithromycin) and glycylcyclines (tigecycline). Med Clin North Am. 2011;95:761\u201391.","journal-title":"Med Clin North Am"},{"key":"930_CR15","doi-asserted-by":"publisher","first-page":"585","DOI":"10.2147\/IDR.S187226","volume":"12","author":"RJ Davidson","year":"2019","unstructured":"Davidson RJ. In vitro activity and pharmacodynamic\/pharmacokinetic parameters of clarithromycin and azithromycin: why they matter in the treatment of respiratory tract infections. Infect Drug Resist. 2019;12:585\u201396. https:\/\/doi.org\/10.2147\/IDR.S187226.","journal-title":"Infect Drug Resist."},{"key":"930_CR16","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1086\/431592","volume":"41","author":"IFN Hung","year":"2005","unstructured":"Hung IFN, Wu AKL, Cheng VCC, Tang BSF, To KW, Yeung CK, et al. Fatal interaction between clarithromycin and colchicine in patients with renal insufficiency: a retrospective Study. Clin Infect Dis. 2005;41:291\u2013300.","journal-title":"Clin Infect Dis"},{"key":"930_CR17","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1345\/aph.1H423","volume":"41","author":"JR Horn","year":"2007","unstructured":"Horn JR, Hansten PD, Chan LN. Proposal for a new tool to evaluate drug interaction cases. Ann Pharmacother. 2007;41:674\u201380.","journal-title":"Ann Pharmacother"},{"key":"930_CR18","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1159\/000350320","volume":"7","author":"Y Hakozaki","year":"2013","unstructured":"Hakozaki Y, Mitani K, Okada C, Terada H, Kobari S. Effective Treatment of intestinal Beh\u00e7et\u2019s disease with long-term, low-dose clarithromycin. Case Rep Gastroenterol. 2013;7:122\u20136.","journal-title":"Case Rep Gastroenterol"},{"key":"930_CR19","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1111\/ctr.12448","volume":"28","author":"A Amanova","year":"2014","unstructured":"Amanova A, Kendi Celebi Z, Bakar F, Caglayan MG, Keven K. Colchicine levels in chronic kidney diseases and kidney transplant recipients using tacrolimus. Clin Transpl. 2014;28:1177\u201383.","journal-title":"Clin Transpl"},{"key":"930_CR20","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1007\/s00296-015-3325-y","volume":"35","author":"O Cohen","year":"2015","unstructured":"Cohen O, Locketz G, Hershko AY, Gorshtein A, Levy Y. Colchicine-clarithromycin-induced rhabdomyolysis in familial mediterranean fever patients under treatment for Helicobacter pylori. Rheumatol Int. 2015;35:1937\u201341.","journal-title":"Rheumatol Int"},{"key":"930_CR21","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s00296-017-3823-1","volume":"38","author":"S Haj Yahia","year":"2018","unstructured":"Haj Yahia S, Ben Zvi I, Livneh A. Colchicine intoxication in familial Mediterranean fever patients using clarithromycin for the treatment of Helicobacter pylori: a series of six patients. Rheumatol Int. 2018;38:141\u20137.","journal-title":"Rheumatol Int"},{"key":"930_CR22","doi-asserted-by":"publisher","first-page":"252","DOI":"10.2310\/8000.2013.130957","volume":"16","author":"A Little","year":"2014","unstructured":"Little A, Tung D, Truong C, Lapinsky S, Burry L. Colchicine overdose with coingestion of nonsteroidal antiinflammatory drugs. CJEM. 2014;16:252\u20136.","journal-title":"CJEM"},{"key":"930_CR23","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1056\/NEJM199503093321004","volume":"332","author":"FJ Baud","year":"1995","unstructured":"Baud FJ, Sabouraud A, Vicaut E, Taboulet P, Lang J, Bismuth C, et al. Brief report: treatment of severe colchicine overdose with colchicine-specific Fab fragments. N Engl J Med. 1995;332:642\u20135.","journal-title":"N Engl J Med"},{"key":"930_CR24","unstructured":"Food and Drug Administration. FDA AEs reporting system (FAERS) public dashboard. https:\/\/www.fda.gov\/Drugs\/GuidanceComplianceRegulatoryInformation\/Surveillance\/AdverseDrugEffects\/ucm070093.htm. Accessed Nov 2019."},{"key":"930_CR25","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s10067-007-0696-9","volume":"27","author":"L Francis","year":"2007","unstructured":"Francis L, Bonilla E, Soforo E, Neupane H, Nakhla H, Fuller C, et al. Fatal toxic myopathy attributed to propofol, methylprednisolone, and cyclosporine after prior exposure to colchicine and simvastatin. Clin Rheumatol. 2007;27:129\u201331.","journal-title":"Clin Rheumatol"},{"key":"930_CR26","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.ejim.2010.09.010","volume":"21","author":"G Cocco","year":"2010","unstructured":"Cocco G, Chu DCC, Pandolfi S. Colchicine in clinical medicine. A guide for internists. Eur J Intern Med. 2010;21:503\u20138.","journal-title":"Eur J Intern Med."},{"key":"930_CR27","first-page":"494","volume":"19","author":"Y Caraco","year":"1992","unstructured":"Caraco Y, Putterman C, Rahamimov R, Ben-Chetrit E. Acute colchicine intoxication\u2013possible role of erythromycin administration. J Rheumatol. 1992;19:494\u20136.","journal-title":"J Rheumatol"},{"key":"930_CR28","volume-title":"The Top 100 DRUG Interactions. A guide to patient management","author":"PD Hansten","year":"2019","unstructured":"Hansten PD, Horn JR. The Top 100 DRUG Interactions. A guide to patient management. Freeland: H&H Publications; 2019."},{"key":"930_CR29","first-page":"181","volume":"55","author":"A Dogukan","year":"2001","unstructured":"Dogukan A, Oymak FS, Taskapan H, G\u00fcven M, Tokgoz BUC. Acute fatal colchicine intoxication in a patient on continuous ambulatory peritoneal dialysis (CAPD). Possible role of clarithromycin administration. Clin Nephrol. 2001;55:181\u20132.","journal-title":"Clin Nephrol."},{"key":"930_CR30","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1345\/aph.1E197","volume":"38","author":"F Rollot","year":"2004","unstructured":"Rollot F, Pajot O, Chauvelot-Moachon L, Nazal EM, K\u00e9la\u00efdi C, Blanche P. Acute colchicine intoxication during clarithromycin administration. Ann Pharmacother. 2004;38:2074\u20137.","journal-title":"Ann Pharmacother"},{"key":"930_CR31","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1097\/01.SMJ.0000163315.02563.B2","volume":"98","author":"VCC Cheng","year":"2005","unstructured":"Cheng VCC, Ho PL, Yuen KY. Two probable cases of serious drug interaction between clarithromycin and colchicine. South Med J. 2005;98:811\u20133.","journal-title":"South Med J"},{"key":"930_CR32","unstructured":"Akdag I, Ersoy A, Kahvecioglu S, Gullulu M DK. Acute colchicine intoxication during clarithromycin administration in patients with chronic renal failure. J Nephrol. 2006;19:515\u20137."},{"key":"930_CR33","first-page":"204","volume":"66","author":"W van der Velden","year":"2008","unstructured":"van der Velden W, Huussen J, Ter Laak H, de S\u00e9vaux R. Colchicine-induced neuromyopathy in a patient with chronic renal failure: the role of clarithromycin. Neth J Med. 2008;66:204\u20136.","journal-title":"Neth J Med"},{"key":"930_CR34","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1097\/RHU.0b013e3181bbbcd7","volume":"15","author":"J McKinnell","year":"2009","unstructured":"McKinnell J, Tayek JA. Short term treatment with clarithromycin resulting in colchicine-induced rhabdomyolysis. J Clin Rheumatol. 2009;15:303\u20135.","journal-title":"J Clin Rheumatol"},{"key":"930_CR35","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.farma.2009.11.002","volume":"34","author":"MJ Izquierdo Pajuelo","year":"2010","unstructured":"Izquierdo Pajuelo MJ, Jim\u00e9nez Delgado JD, Rangel Mayoral JF, Liso Rubio FJ. Interacci\u00f3n mortal entre colchicina y claritromicina. Farm Hosp. 2010;34:309\u201310.","journal-title":"Farm Hosp"},{"key":"930_CR36","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1097\/RHU.0b013e31828639e0","volume":"19","author":"J-B Kim","year":"2013","unstructured":"Kim J-B, Kim S, Lee T, Lee YS, Cho YS, Moon H-B, et al. Colchicine-induced rhabdomyolysis caused by interaction with clarithromycin in a patient with Behcet disease. J Clin Rheumatol. 2013;19:108\u20139.","journal-title":"J Clin Rheumatol"},{"key":"930_CR37","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1093\/ckj\/sft129","volume":"6","author":"ZK \u00c7elebi","year":"2013","unstructured":"\u00c7elebi ZK, Akturk S, Oktay EI, Duman N, Keven K. Colchicine-induced rhabdomyolysis following a concomitant use of clarithromycin in a haemodialysis patient with familial Mediterranean fever. Clin Kidney J. 2013;6:665\u20136.","journal-title":"Clin Kidney J"},{"issue":"3","key":"930_CR38","doi-asserted-by":"publisher","first-page":"001066","DOI":"10.12890\/2019_001066","volume":"6","author":"JM Olmos-Mart\u00ednez","year":"2019","unstructured":"Olmos-Mart\u00ednez JM, Molina H, Salas C, Olmos JM, Hern\u00e1ndez JL. Acute clchicine-induced neuromyopathy in a patient treated with atorvastatin and clarithromycin. Eur J Case Rep Intern Med. 2019;6(3):001066. https:\/\/doi.org\/10.12890\/2019_001066.","journal-title":"Eur J Case Rep Intern Med."}],"container-title":["Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-020-00930-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40264-020-00930-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-020-00930-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T19:46:05Z","timestamp":1617911165000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40264-020-00930-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,9]]},"references-count":38,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["930"],"URL":"https:\/\/doi.org\/10.1007\/s40264-020-00930-7","relation":{},"ISSN":["0114-5916","1179-1942"],"issn-type":[{"value":"0114-5916","type":"print"},{"value":"1179-1942","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,9]]},"assertion":[{"value":"9 April 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"This project was supported by grant R01HS025984 from the Agency for Healthcare Research and Quality. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Agency for Healthcare Research and Quality.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"All authors have completed the ADIS uniform disclosure. There was no support from any organization for the submitted work; no financial relationships with any organizations that might have an interest in the submitted work in the previous 3\u00a0years, and no other relationships or activities that could appear to have influenced the submitted work.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Reports of colchicine\u2013clarithromycin drug interactions in FAERS can be publicly accessed via:","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}},{"value":"The authors affirm that the manuscript is an honest, accurate, and transparent account of the study being reported; that no important aspects of the study have been omitted; and that any discrepancies from the study as planned (and, if relevant, registered) have been explained.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}}]}}